Drug Profile
R 91767
Alternative Names: 8-Chloro-tibo; R 091767Latest Information Update: 11 Dec 2000
Price :
$50
*
At a glance
- Originator Janssen L.P.; Tibotec BVBA
- Class Antiretrovirals
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 11 Dec 2000 Discontinued-Clinical for HIV-1 infections in Belgium (PO)
- 29 Oct 1999 Profile reviewed but no significant changes made
- 23 Apr 1996 Investigation in HIV-1 infections in Belgium (PO)